Zevtera / Mabelio (ceftobiprole)

Zevtera / Mabelio (ceftobiprole)

Indicaton

Acute bacterial skin and skin structure infections (ABSSSI)

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Marketed
Partnering status

Partnered
Partner

Innoviva Specialty Therapeutics

You may also be interested in

Fosmanogepix

Fosmanogepix is a novel-class i.v. and oral antifungal with activity against yeasts and molds.

Phase III started

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Hospital- and community-acquired pneumonia

Marketed